Dear Friends,

A Weak …..Week Ahead. Indices Are Showing Signs Of Tiring And May Fizzle Out During The Week. Please Note: Figures In Brackets Are For Nifty. All Prices / Levels Mentioned In This post Are Cash Market Prices / Levels Only)

Always Trade With Trend!! Stoplosses Are A Must! Avoid Trading If Not A Quick Trader. Invest Wisely, Trade Sharp. Small Losses Are Better Than Big Holes In Pockets. Today, Indices Need To Stay Above 10615 (3150). Resistances Exists At 10675 (3165) And 10745 (3185). Support Exists At 10535 (3130). Breach Of Support Will Lead To 10480 (3115) & 10346 (3080).Be Cautious With Long Positions. Maintain Trailing Stoplosses.

Pharma Stocks May Show Healthy Recovery. Stocks To Be Kept Under Scanner Are Matrix, Glaxo, Cipla, Aurobindo, Dr. Reddy’s, Nicholas Piramal, Orchid Chem., Pfizer, Surya Pharma, Aventis & Rpg Lifesciences.

Matrix May Rise Upto 277. If Crosses 280 Then Expected To Hit 300 Or More In Very Short Term. Stoploss Below 264 On Closing Basis Should Suffice.

Rpg Lifesciences – Above 180 Will Shoot To Hit 195 In Matter Of Hours Only.

Aurobindo Pharma – Buy With Stoploss Placed At 574 On Closing Basis. Expect A Price Of 625.

Apollo Hospital – Buy With Stoploss Placed At 517. Above 535 Stock Will Be Unstoppable. Targets For The Stock Are 555 & 585.

Cipla Maybe Bought With Strict Stoploss At 540. Targets For The Stock Are 570 & 585.

Dr. Reddy’s – Above 1340, Sure To Hit 1400. Strong Support At 1290.

Pfizer – World Leader Will Show It’s Class Above 1060 And Notch Gains Upto 1170.

Aventis Pharma – Stock Is Already Up & Moving. Targets Are 1920 & 2020.

Nicholas Piramal – Expected Targets Are 263 & 271 In Extreme Short Term.

Surya Pharma Has Already Been Covered Earlier.

Essel Packaging Has Been A Major Beneficiary Of The Budget. It’s Real Potential Is Yet To Realise. From Current Levels Of 378 Expect It To Move Upto 450 In Extreme Short Term.

Hexaware, Hindalco, Engineers India & Basf Are Looking Very Very Hot!!!

Take Care!!!

(Read Disclaimer on the first post related to this segment.)

Popularity: 1% [?]